4.4 Article

MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells

Journal

ENDOCRINE-RELATED CANCER
Volume 18, Issue 6, Pages 711-719

Publisher

BIOSCIENTIFICA LTD
DOI: 10.1530/ERC-10-0257

Keywords

-

Funding

  1. Institut National du Cancer (INCa, France) [PL0079, 07/3D1616/Pdoc-110-32/NG-NC, R06080AA]
  2. French Medical Research (FRM, France)
  3. European Community (MICROENVIMET) [FP7-HEALTH-F2-2008-201279]
  4. CHUN-CNRS
  5. Gunnar Nilsson Cancer Foundation
  6. Sharon D Lund Foundation
  7. Swedish Cancer Society
  8. Swedish Research Council
  9. Medical Faculty, Lund University
  10. Soderberg, Pediatric Cancer
  11. Anna-Lisa and Sven-Erik Lundgren Foundation
  12. Knut and Alice Wallenberg Foundation
  13. Lund City Jubileumsfond
  14. John and Augusta Persson Foundation for Medical Research
  15. Maggie Stephens Foundation
  16. Inga-Britt and Arne Lundberg Foundation
  17. H J Forssman Foundation for Medical Research
  18. Royal Physiographic Society

Ask authors/readers for more resources

The molecular mechanism responsible for the antitumor activity of histone deacetylase inhibitors (HDACi) remains elusive. As HDACi have been described to alter miRNA expression, the aim of this study was to characterize HDACi-induced miRNAs and to determine their functional importance in the induction of cell death alone or in combination with other cancer drugs. Two HDACi, trichostatin A and vorinostat, induced miR-129-5p overexpression, histone acetylation and cell death in BCPAP, TPC-1, 8505C, and CAL62 cell lines and in primary cultures of papillary thyroid cancer (PTC) cells. In addition, miR-129-5p alone was sufficient to induce cell death and knockdown experiments showed that expression of this miRNA was required for HDACi-induced cell death. Moreover, miR-129-5p accentuated the anti-proliferative effects of other cancer drugs such as etoposide or human a-lactalbumin made lethal for tumor cells (HAMLET). Taken together, our data show that miR-129-5p is involved in the antitumor activity of HDACi and highlight a miRNA-driven cell death mechanism. Endocrine-Related Cancer (2011) 18 711-719

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available